These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 33624292)
41. [Primary cutaneous CD4+ small to medium-sized T-cell lymphoma in an adolescent patient]. Stähr K; Lang S; Mattheis S HNO; 2020 Sep; 68(9):695-697. PubMed ID: 32728760 [TBL] [Abstract][Full Text] [Related]
42. Long-term follow-up and management of small and medium-sized CD4 Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070 [TBL] [Abstract][Full Text] [Related]
43. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma. Lan TT; Brown NA; Hristov AC Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194 [TBL] [Abstract][Full Text] [Related]
44. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria. Bakr F; Wain EM; Wong S; Palmer R; Robson A Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212 [TBL] [Abstract][Full Text] [Related]
47. Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients. Hurabielle C; Sbidian E; Beltraminelli H; Bouchindhomme B; Chassagne-Clément C; Balme B; Bossard C; Delfau-Larue MH; Wolkenstein P; Chosidow O; Cordonnier C; Toma A; Pautas C; Ortonne N Hum Pathol; 2018 Jan; 71():100-108. PubMed ID: 29107664 [TBL] [Abstract][Full Text] [Related]
48. T-cell receptor gene rearrangement studies as a diagnostic tool in lymphoproliferative skin diseases. Lessin SR; Rook AH Exp Dermatol; 1993 Mar; 2(2):53-62. PubMed ID: 8156170 [TBL] [Abstract][Full Text] [Related]
49. Adnexotropism as a Histopathological Clue for the Diagnosis of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder. Pérez González YC; Llamas Velasco MDM; Díaz Recuero JL; Machan S; Núñez Hipolito L; Piris Pinilla MA; Rodríguez Pinilla SM Am J Dermatopathol; 2020 May; 42(5):383-384. PubMed ID: 31313694 [No Abstract] [Full Text] [Related]
50. Of lymphocytes and cutaneous epithelium: keratoacanthomatous hyperplasia in CD30+ lymphoproliferative disorders and CD30+ cells associated with keratoacanthoma. Resnik KS; Kutzner H Am J Dermatopathol; 2010 May; 32(3):314-315. PubMed ID: 19915450 [No Abstract] [Full Text] [Related]
51. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Kim EJ; Aria AB; Wilmas K; Lewis DJ; Torres-Cabala CA; Nunez C; Dabaja BS; Duvic M Pediatr Dermatol; 2019 Jan; 36(1):e23-e26. PubMed ID: 30548331 [TBL] [Abstract][Full Text] [Related]
52. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma? Gomez Vazquez M; Navarra Amayuelas R Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522 [TBL] [Abstract][Full Text] [Related]
53. Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma? Beltraminelli H; Müllegger R; Cerroni L J Cutan Pathol; 2010 Jan; 37(1):81-4. PubMed ID: 19602068 [TBL] [Abstract][Full Text] [Related]
54. Cutaneous CD4+/CD56+ hematodermic neoplasm. Zindanci I; Kavala M; Buyukbabani N; Kocaturk E; Koc M Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079332 [TBL] [Abstract][Full Text] [Related]
55. The role of immunohistochemistry in the diagnosis of cutaneous lymphoma. Smoller BR Adv Dermatol; 1997; 13():207-34. PubMed ID: 9551145 [No Abstract] [Full Text] [Related]